Frank E. Thomas

2013

In 2013, Frank E. Thomas earned a total compensation of $1.2M as President and Chief Operating Officer at AMAG Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$212,500
Option Awards$314,858
Salary$423,077
Stock Awards$216,265
Other$7,650
Total$1,174,350

Thomas received $423.1K in salary, accounting for 36% of the total pay in 2013.

Thomas also received $212.5K in non-equity incentive plan, $314.9K in option awards, $216.3K in stock awards and $7.7K in other compensation.

Rankings

In 2013, Frank E. Thomas' compensation ranked 5,934th out of 12,286 executives tracked by ExecPay. In other words, Thomas earned more than 51.7% of executives.

ClassificationRankingPercentile
All
5,934
out of 12,286
52nd
Division
Manufacturing
2,060
out of 4,612
55th
Major group
Chemicals And Allied Products
603
out of 1,466
59th
Industry group
Drugs
433
out of 1,160
63rd
Industry
Pharmaceutical Preparations
347
out of 890
61st
Source: SEC filing on April 15, 2016.

Thomas' colleagues

We found five more compensation records of executives who worked with Frank E. Thomas at AMAG Pharmaceuticals in 2013.

2013

Greg Madison

AMAG Pharmaceuticals

Former Executive Vice President and Chief Commercial Officer

2013

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2013

Christopher White

AMAG Pharmaceuticals

Senior Vice President and Chief Business Officer

2013

Scott Townsend

AMAG Pharmaceuticals

General Counsel

2013

Scott Holmes

AMAG Pharmaceuticals

Chief Accounting Officer

You may also like